SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-030681
Filing Date
2017-02-03
Accepted
2017-02-03 16:01:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d339959dsc13ga.htm SC 13G/A 38902
  Complete submission text file 0001193125-17-030681.txt   40298
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Subject) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83933 | Film No.: 17572060
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PUMA BIOTECHNOLOGY INC. 10880 WILSHIRE BOULEVARD, SUITE 2150 LOS ANGELES CA 90024
Business Address
WILSON TROY EDWARD (Filed by) CIK: 0001589597 (see all company filings)

Type: SC 13G/A